{"id":"https://openalex.org/W3173907293","doi":"https://doi.org/10.2337/db21-783-p","title":"783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV","display_name":"783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV","publication_year":2021,"publication_date":"2021-06-01","ids":{"openalex":"https://openalex.org/W3173907293","doi":"https://doi.org/10.2337/db21-783-p","mag":"3173907293"},"language":"en","primary_location":{"id":"doi:10.2337/db21-783-p","doi":"https://doi.org/10.2337/db21-783-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db21-783-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025169113","display_name":"Bernard H. Charbonnel","orcid":"https://orcid.org/0000-0002-2117-9279","observed_orcids":["https://orcid.org/0000-0002-2117-9279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"BERNARD CHARBONNEL","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033587716","display_name":"Samuel E. Dagogo-Jack","orcid":"https://orcid.org/0000-0001-5318-9677","observed_orcids":["https://orcid.org/0000-0001-5318-9677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SAMUEL DAGOGO-JACK","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026602252","display_name":"Christopher Paul Cannon","orcid":"https://orcid.org/0000-0003-4596-2791","observed_orcids":["https://orcid.org/0000-0003-4596-2791"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"CHRISTOPHER P. CANNON","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029467844","display_name":"David Z.I. Cherney","orcid":"https://orcid.org/0000-0003-4164-0429","observed_orcids":["https://orcid.org/0000-0003-4164-0429"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DAVID CHERNEY","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"FRANCESCO COSENTINO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"FRANCESCO COSENTINO","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071945904","display_name":"Darren K. McGuire","orcid":"https://orcid.org/0000-0002-6412-7989","observed_orcids":["https://orcid.org/0000-0002-6412-7989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"DARREN K. MCGUIRE","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108128867","display_name":"Weichung Shih","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"WEICHUNG J. SHIH","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100760711","display_name":"Jie Liu","orcid":"https://orcid.org/0000-0002-3868-1660","observed_orcids":["https://orcid.org/0000-0002-3868-1660"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JIE LIU","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078590370","display_name":"Annpey Pong","orcid":"https://orcid.org/0000-0002-3377-5318","observed_orcids":["https://orcid.org/0000-0002-3377-5318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ANNPEY PONG","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026935251","display_name":"Ira Gantz","orcid":"https://orcid.org/0000-0002-6565-7113","observed_orcids":["https://orcid.org/0000-0002-6565-7113","https://orcid.org/0000-0001-8572-5614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"IRA GANTZ","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051174907","display_name":"Robert C. Frederich","orcid":"https://orcid.org/0000-0002-5175-3112","observed_orcids":["https://orcid.org/0000-0002-5175-3112"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"ROBERT FREDERICH","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112568961","display_name":"James P. Mancuso","orcid":"https://orcid.org/0000-0002-5722-1360","observed_orcids":["https://orcid.org/0000-0002-5722-1360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JAMES P. MANCUSO","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059098934","display_name":"Richard E. Pratley","orcid":"https://orcid.org/0000-0002-2912-1389","observed_orcids":["https://orcid.org/0000-0002-2912-1389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RICHARD E. PRATLEY","raw_affiliation_strings":["Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nantes, France, Memphis, TN, Boston, MA, Toronto, ON, Canada, Stockholm, Sweden, Dallas, TX, Piscataway, NJ, Kenilworth, NJ, Collegeville, PA, Groton, CT, Orlando, FL","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1871,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.49920255,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"70","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ertugliflozin","display_name":"ertugliflozin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9700000286102295},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.925000011920929},{"id":"https://openalex.org/keywords/cardiorenal-outcomes","display_name":"cardiorenal outcomes","score":0.8479999899864197},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.8889999985694885},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.9330000281333923},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":1.0},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8510000109672546},{"id":"https://openalex.org/keywords/heart-failure-hospitalization","display_name":"heart failure hospitalization","score":0.7739999890327454},{"id":"https://openalex.org/keywords/renal-outcomes","display_name":"renal outcomes","score":0.640999972820282},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease","display_name":"atherosclerotic cardiovascular disease","score":0.8619999885559082},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.46799999475479126},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.7059999704360962},{"id":"https://openalex.org/keywords/dialysis","display_name":"dialysis","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8498184680938721},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6361507177352905},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5491226315498352},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4909956753253937},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4655521512031555},{"id":"https://openalex.org/C2779978075","wikidata":"https://www.wikidata.org/wiki/Q202301","display_name":"Dialysis","level":2,"score":0.4560243785381317},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.44299885630607605},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4378291368484497},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4134068489074707},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38855189085006714},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3442574143409729},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.30235347151756287},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2454150915145874},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.18959641456604004},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.057820528745651245},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db21-783-p","doi":"https://doi.org/10.2337/db21-783-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db21-783-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220790895","https://openalex.org/W4292495782","https://openalex.org/W3174625521","https://openalex.org/W3088653895","https://openalex.org/W4407132939","https://openalex.org/W4361195578","https://openalex.org/W2890465901","https://openalex.org/W3049399795","https://openalex.org/W3083433180","https://openalex.org/W7155085328"],"abstract_inverted_index":{"VERTIS":[0,108,116,191],"CV":[1,23,37,47,109],"was":[2,30],"the":[3,9,26,43,56,70,152,173,187,193],"cardiovascular":[4],"(CV)":[5],"outcome":[6],"trial":[7],"for":[8,34,42,51,164],"SGLT2":[10],"inhibitor":[11],"ertugliflozin,":[12],"conducted":[13],"in":[14,90,115,140,200],"patients":[15,114,201],"with":[16,202],"type":[17],"2":[18],"diabetes":[19],"(T2D)":[20],"and":[21,55,81,131,157,361,506],"atherosclerotic":[22],"disease.":[24],"In":[25],"overall":[27],"population,":[28],"ertugliflozin":[29,196],"noninferior":[31],"to":[32],"placebo":[33],"major":[35],"adverse":[36],"events":[38],"(MACE).":[39],"Although":[40],"superiority":[41],"composite":[44,58,86],"endpoint":[45],"of":[46,62,74,107,151,172,195,208],"death":[48],"or":[49,95,139],"hospitalization":[50],"heart":[52],"failure":[53],"(HHF)":[54],"renal":[57,85,96],"(that":[59],"included":[60],"doubling":[61],"serum":[63],"creatinine":[64],"from":[65,92],"BL)":[66],"were":[67,162,183,204],"not":[68],"met,":[69],"prespecified":[71,83],"secondary":[72],"objective":[73],"HHF":[75],"showed":[76,98],"a":[77,82],"30%":[78],"risk":[79],"reduction":[80],"exploratory":[84],"(sustained":[87],"\u226540%":[88],"decrease":[89],"eGFR":[91],"BL,":[93],"dialysis/transplantation,":[94],"death)":[97],"improved":[99],"kidney":[100],"outcomes.":[101],"This":[102],"analysis":[103],"assessed":[104],"cardiorenal":[105,165,198],"endpoints":[106],"by":[110,167],"BL":[111,119,168,188,209],"GLA.Among":[112],"8246":[113],"CV,":[117,192],"at":[118,147],"6292":[120],"(76%)":[121],"used":[122,144],"metformin,":[123,154],"3900":[124],"(47%)":[125],"insulin,":[126,155],"3390":[127],"(41%)":[128],"sulfonylureas":[129],"(SU),":[130],"911":[132],"(11%)":[133],"dipeptidyl":[134],"peptidase-4":[135],"inhibitors":[136],"(DPP4i),":[137],"alone":[138],"combination":[141],"therapy":[142],"(67%":[143],">1":[145],"GLA":[146,174,189],"BL).":[148],"For":[149],"each":[150],"GLAs,":[153],"SU,":[156],"DPP4i,":[158],"no":[159],"significant":[160],"differences":[161],"observed":[163],"outcomes":[166,182,199],"use":[169],"(yes,":[170],"no)":[171],"(FIGURE;":[175],"all":[176],"interaction":[177],"P":[178],"values":[179],">0.05).":[180],"Cardiorenal":[181],"generally":[184,205],"similar":[185],"across":[186],"subgroups.In":[190],"effects":[194],"on":[197],"T2D":[203],"consistent":[206],"regardless":[207],"GLA.View":[210],"largeDownload":[211,213],"slideView":[212],"slide":[214],"DisclosureB.":[215],"Charbonnel:":[216],"Advisory":[217,348,463],"Panel;":[218,349,464],"Self;":[219,238,246,254,259,266,276,284,296,326,339,350,374,400,434,465,476,494,527],"AstraZeneca,":[220,328,437,466,497],"Boehringer":[221,385,403,440,479,498],"Ingelheim":[222,386,404,441,480,499],"International":[223,442,481],"GmbH,":[224,443,482],"Lilly":[225,360,448,505],"Diabetes,":[226,449],"Merck":[227,247,260,299,332,366,420,450,467,511,528],"&":[228,248,262,301,333,367,414,421,451,469,512,530,537],"Co.,":[229,249,334,368,422,452,513],"Inc.,":[230,256,278,282,286,308,312,318,331,335,353,365,369,371,377,379,388,394,402,406,423,436,453,473,510,514,518],"Mundipharma":[231,486],"International,":[232,487],"Novo":[233,309,424,458,488,515],"Nordisk,":[234,310,459,516],"Sanofi,":[235,315,372],"Speaker's":[236,474],"Bureau;":[237,475],"Takeda":[239],"Pharmaceutical":[240,320],"Company":[241],"Limited.":[242],"I.":[243],"Gantz:":[244],"Employee;":[245,253,275,279,526],"Inc.":[250,271,290,344,429],"R.":[251,291],"Frederich:":[252],"Pfizer":[255,270,277,281,285,289,311,370,428,472,517],"Other":[257,294,432],"Relationship;":[258,295,433],"Sharp":[261,300,468,529,536],"Dohme":[263,302,470,531,538],"Corp.,":[264,303,471],"Stock/Shareholder;":[265,283,287,338],"Bristol-Myers":[267,389,407,483],"Squibb":[268,390,408,484],"Company,":[269,307,362,391,396,409,418,485,507],"J.":[272,521,524],"P.":[273,346],"Mancuso:":[274],"Spouse/Partner;":[280,288],"E.":[292],"Pratley:":[293],"Hanmi":[297],"Pharmaceutical,":[298],"Metavention,":[304],"Monster":[305],"Energy":[306],"Poxel":[313],"SA,":[314],"Scohia":[316],"Pharma":[317,383,426],"Sun":[319],"Industries":[321],"Ltd.":[322],"S.":[323],"Dagogo-jack:":[324],"Consultant;":[325,373,493],"Abbott,":[327],"Janssen":[329,363,412,444],"Pharmaceuticals,":[330,364,376,387,405,509],"Sanofi":[336],"US,":[337],"Aerami":[340],"Therapeutics,":[341,358,381,496],"Jana":[342],"Care":[343],"C.":[345],"Cannon:":[347],"Aegerion":[351],"Pharmaceuticals":[352],"Amarin":[354],"Corporation":[355],"plc,":[356],"Corvidia":[357],"Eli":[359,504],"Alnylam":[375],"Amgen":[378,401],"Applied":[380,495],"Ascendis":[382],"A/S,":[384],"HLS":[392],"Therapeutics":[393],"Kowa":[395,417],"Ltd.,":[397,419,427,501],"Research":[398,413],"Support;":[399],"Daiichi":[410],"Sankyo,":[411],"Development,":[415],"LLC,":[416],"Nordisk":[425],"D.":[430,490],"Cherney:":[431],"AbbVie":[435],"Bayer":[438,477],"AG,":[439,478],"Scientific":[445],"Affairs,":[446],"LLC.,":[447],"Mitsubishi-Tanabe,":[454],"Maze":[455],"Inc,":[456],"Prometic,":[457],"Sanofi.":[460,519],"F.":[461],"Cosentino:":[462],"Nordisk.":[489],"K.":[491],"Mcguire:":[492],"(Canada)":[500],"CSL":[502],"Behring,":[503],"Lexicon":[508],"W.":[520],"Shih:":[522],"None.":[523],"Liu:":[525],"Corp.":[532],"A.":[533],"Pong:":[534],"None.FundingMerck":[535],"Corp":[539]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2021-07-05T00:00:00"}